Cranbury-based biopharmaceutical company Amicus Therapeutics Inc. announced Monday the appointment of Jay A. Barth as chief medical officer effective immediately.
According to the announcement, the company also announced the promotion of Bradley L. Campbell from chief business officer to chief operating officer, effective Dec. 2013.
Barth will be responsible for all clinical development activities as well as regulatory affairs.
Campbell will head several departments including business development, program management, commercial planning, patient and professional advocacy, and technical operations. He will also oversee preclinical research and development, the announcement said.
ALSO ON NJBIZ:
Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.View Comment Policy